 |
|
L-alanosine
An amino acid analogue and antibiotic derived from the bacterium Streptomyces alanosinicus with antimetabolite and potential antineoplastic activities. L-alanosine inhibits adenylosuccinate synthetase, which converts inosine monophospate (IMP) into adenylosuccinate, an intermediate in purine metabolism. L-alanosine-induced disruption of de novo purine biosynthesis is potentiated by methylthioadenosine phosphorylase (MTAP) deficiency. The clinical use of this agent may be limited by its toxicity profile. MTAP is a key enzyme in the adenine and methionine salvage pathways. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | alanosine
L-alanosine sodium | | | | Code name: | | SDX-102 | | | | Chemical structure names: | | - 3-(hydroxynitrosoamino)-L-alanine
- L-2-amino-3-(hydroxynitrosoamino)propionic acid
- L-2-amino-3-[(N-nitroso)hydroxylamino]propionic acid
| | |
|
|
